HCAT insider buying and SEC filings, explained
Health Catalyst, Inc. · CIK 1636422
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$106K
Insiders who bought
1
Sold (not marked 10b5-1)
$128K
Planned sales (10b5-1)
$72K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 14, 2026 | Purchase (code P) | Simeon Kohl (CEO and Director) bought 59,000 shares at $1.79 ($106K), reported as a purchase (code P). Holdings up 2% to 2,856,385 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 16, 2026 |
| Dec 5, 2025 | Planned (10b5-1) | Benjamin Landry (General Counsel) sold 27,425 shares at $2.64 ($72K), marked as a 10b5-1 plan trade. Holdings down 22% to 100,000 shares. | SEC filing Filed Dec 9, 2025 |
| Dec 4, 2025 | Sale | Julie Larson-Green (Director) sold 47,997 shares at $2.67 ($128K). Holdings down 39% to 73,573 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 9, 2025 |
37 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow HCAT in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.